Dicephin

Ceftriaxone USP

Composition : Ceftriaxone Sodium USP 250mg (IV/IM), 500mg (IV/IM), 1gm (IV/IM) & 2gm (IV) Injection.

Indication : Dicephin is indicated for the treatment of the following infections when caus ed by susceptible organisms: lower respiratory tract infections, skin and skin structure infections, urinary tract infections, uncomplicated gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, bone and joint infections, meningitis and surgical prophylaxis.

Dosage and administration : Dicephin may be administered intra venously or intramuscularly. Adults : The usual adult daily dose is 1 to 2 grams given once a day (or in equally divided doses twice a day) depending on the type and severity of infection. The total daily dose should not exceed 4 grams. For surgical prophylaxis, a single dos e of 1 gram administered intravenously 1/2 to 2 hours before surgery is recommended. Children : For the treatment of skin and skin structure infections, the recommended total daily dose is 50 to 75 mg/kg given once a day (or in equally divided doses twice a day). The total daily dose should not exceed 2 grams. In the treatment of meningitis, it is recommended that the initial therapeutic dose be 100mg/kg (not to exceed 4 grams) or as directed by the registered physician.

Use in pregnancy and lactation : Ceftriaxone has been assigned to pregnancy category B by the FDA.

Packing :1 Combipack / Injection.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.